Sucampo Pharma (SCMP) Tops Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Sucampo Pharma (SCMP) Tops Q2 EPS by 1c

Mizuho Securities Downgrades Sucampo Pharmaceuticals (SCMP) to Neutral

August 4, 2016 6:24 AM EDT

Mizuho Securities downgraded Sucampo Pharmaceuticals (NASDAQ: SCMP) from Buy to Neutral with a price target of $13.00.

Analyst Irina Koffler commented, "After the recent run up in SCMP we are moving to the sidelines due to our increased caution about clinical risk and... More

Mizuho Securities Reiterates Buy on Sucampo Pharma (SCMP) as Amitiza Royalies Drives 2Q Beat

August 3, 2016 9:12 AM EDT

Mizuho Securities reiterated a Buy rating and $14.00 price target on Sucampo Pharmaceuticals (NASDAQ: SCMP) following the company's 2Q earnings report. SCMP reported revenues of $52.0M and $0.23 in EPS vs. consensus of $48.6M and $0.22. The beat was driven primarily by higher royalty revenue from Amitiza... More